Literature DB >> 4334088

Clinical experience with mitomycin C (NSC-26980).

R M Whittington, H P Close.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4334088

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  6 in total

Review 1.  Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-08       Impact factor: 1.798

2.  Pharmacokinetics of mitomycin C in non-oat cell carcinoma of the lung.

Authors:  R G Buice; H B Niell; P Sidhu; B J Gurley
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer.

Authors:  S D Chetiyawardana; M H Cullen; R C Joshi; C M Woodroffe
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 4.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 5.  Anticancer drug-induced kidney disorders.

Authors:  P E Kintzel
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.228

6.  Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells.

Authors:  Seog-Young Kim; Dae-Hee Lee; Xinxin Song; David L Bartlett; Yong Tae Kwon; Yong J Lee
Journal:  Apoptosis       Date:  2014-11       Impact factor: 4.677
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.